Findings from several studies have shown that expression profile of Gal-9 is highly elevated in many inflammatory autoimmune diseases, such as systemic lupus erythematosus (39), rheumatoid arthritis (RA) (40, 41), and systemic sclerosis (42). Here, LGALS9 is linked to systemic sclerosis.